NYSEAMERICAN:LGL LGL Group Q3 2025 Earnings Report $6.83 -0.02 (-0.29%) Closing price 07/17/2026 04:10 PM EasternExtended Trading$6.84 +0.01 (+0.15%) As of 07/17/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast LGL Group EPS ResultsActual EPS$0.14Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ALGL Group Revenue ResultsActual Revenue$0.66 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ALGL Group Announcement DetailsQuarterQ3 2025Date11/13/2025TimeBefore Market OpensConference Call DateThursday, November 13, 2025Conference Call Time9:00AM ETUpcoming EarningsLGL Group's Q2 2026 earnings is estimated for Thursday, August 13, 2026, based on past reporting schedules, with a conference call scheduled on Monday, August 10, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly Report(10-Q) LGL Group Earnings HeadlinesLGL Group (NYSEAMERICAN:LGL) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?July 9, 2026 | americanbankingnews.comLGL Announces Exploration of Potential Spin-off of MTronPTI BusinessJuly 7, 2026 | businesswire.comA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.July 18 at 1:00 AM | Porter & Company (Ad)The LGL Group Inc.: The LGL Group, Inc. Announces Appointment of Jason Lamb as Chief Executive OfficerJune 27, 2026 | finanznachrichten.deLGL.RT The LGL Group, Inc. Subs RtJune 27, 2026 | seekingalpha.comLGL Group Launches Tradable Rights Offering on OTC MarketsJune 26, 2026 | tipranks.comSee More LGL Group Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like LGL Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LGL Group and other key companies, straight to your email. Email Address About LGL GroupLGL Group (NYSEAMERICAN:LGL) Inc is a United States–based company specializing in the development and commercialization of digital pathology and molecular imaging systems for research and clinical laboratories. The company’s core focus lies in enabling high-resolution visualization and quantitative analysis of tissue samples, helping scientists and pathologists accelerate biomarker discovery and diagnostic workflows. LGL Group’s platform combines advanced optics, automated slide scanning and image analysis software to deliver end-to-end solutions tailored to oncology, immunology and neuroscience research. The company’s flagship offerings include whole-slide scanners capable of rapid, high-throughput scanning at resolutions suited for detailed morphometric and fluorescence studies. Complementary image analysis software provides tools for cell counting, phenotyping and spatial tissue analysis via customizable algorithms. LGL Group also offers support reagents and consumables designed to streamline sample preparation and ensure reproducible imaging results, as well as service plans for equipment maintenance and software updates. LGL Group’s products are marketed primarily in North America and Europe through a combination of direct sales and distribution partnerships. The company serves a diverse customer base that includes academic research centers, pharmaceutical and biotechnology organizations, contract research laboratories and hospital pathology departments. By integrating hardware, software and application support, LGL Group aims to address the growing demand for quantitative digital pathology solutions in both drug development and clinical diagnostic settings.View LGL Group ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 07/13- 07/17The Market Sold Alcoa After Earnings—But It May Be Missing the Real StoryTSMC Just Gave AI Chip Bulls Another Reason to Stay ConfidentAehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue GrowthWhy Intuitive Surgical’s Strong Quarter Still Spooked InvestorsNetflix May Be Cheap Enough to Tempt Buyers After Earnings DropGE Aerospace Faces a Prove-It Moment in Q2 Earnings Upcoming Earnings General Motors (7/21/2026)Northrop Grumman (7/21/2026)America Movil (7/21/2026)Alphabet (7/21/2026)Chubb (7/21/2026)Capital One Financial (7/21/2026)Interactive Brokers Group (7/21/2026)Charles Schwab (7/21/2026)Danaher (7/21/2026)Novartis (7/21/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
